Bentham Science Logo
Journal Cover

Track Your Manuscript:


Current Alzheimer Research

Volume 19, 14 Issues, 2022
ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)
This journal supports open access

Aims & Scope

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Current Alzheimer Research

,

Volume 18

-

Number 14



Research Article

The Interaction of Dynamic Cerebral Autoregulation and Neurovascular Coupling in Cognitive Impairment

, 18(14): 1067 - 1076

Lucy C. Beishon*, Kannakorn Intharakham*, Victoria J. Haunton, Thompson G. Robinson and Ronney B. Panerai


DOI: 10.2174/1567205019666211227102936


Research Article

Long-term Physical Exercise Improves Finger Tapping of Patients with Alzheimer's Disease

, 18(14): 1077 - 1086

Linlin Zhao*, Guanghua Liu*, Lingli Zhang, Yuxiang Du, Le Lei, Xiaojing Zhang, Yilong Zhao and Deng Shen


DOI: 10.2174/1567205018666211215150157


Research Article

Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer’s Disease: A 6-Month Retrospective Follow-Up Study

, 18(14): 1087 - 1092

Fatma Sena Dost, Derya Kaya, Mehmet Selman Ontan, Neziha Erken, Esra Ateş Bulut, Ali Ekrem Aydin and Ahmet Turan Isik*


DOI: 10.2174/1567205019666211221125255


Research Article

Olfactory Function, Genetic Predisposition, and Cognitive Performance in Chinese Adults

, 18(14): 1093 - 1103

Xianyi Yang, Jing Si, Shuchun Lin, Xiaofeng Zhou, Hui Zhang, Zhonghan Sun, Yanni Pu, Qian Li, Jiange Qiu, Lin Wang, Chunhua Song, Changzheng Yuan*, Xiaofeng Wang* and Yan Zheng*


DOI: 10.2174/1567205019666211222151851


Research Article

Blink Rate Study in Patients with Alzheimer's Disease, Mild Cognitive Impairment and Subjective Cognitive Decline

, 18(14): 1104 - 1110

Fabrizia D’Antonio*, Maria I. De Bartolo, Gina Ferrazzano, Micaela Sepe Monti, Letizia Imbriano, Alessandro Trebbastoni, Alfredo Berardelli and Antonella Conte


DOI: 10.2174/1567205019666211227102706




Research Article



Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Published Contents

Editor's Choice



Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer’s and Parkinson’s Disease

, 2021; 18(9): 695 - 700

Sara García*, Olaya Amor-Gutiérrez, María Palomares-Albarrán, Celia Toyos-Rodríguez, Fernando Cuetos, Carmen Martínez, Agustín Costa-García, Maria Teresa Fernández-Sánchez, Alfredo de la Escosura-Muñiz and Antonello Novelli


DOI: 10.2174/1567205018666211117101216



Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study

, 2021; 18(8): 607 - 622

Anna Mengr, Lucie Hrubá, Aneta Exnerová, Martina Holubová, Andrea Popelová, Blanka Železná, Jaroslav Kuneš and Lenka Maletínská*


DOI: 10.2174/1567205018666210922110652



A Novel Probiotic Formula, BIOCG, Protects Against Alzheimer’s-Related Cognitive Deficits via Regulation of Dendritic Spine Dynamics

, 2021; 18(7): 558 - 572

Miao Sun*, Wenchenyang Bao, Chengyu Huang, Ziyue Xia, Changliang Zhang, Guangxian Wang, Runxin Wang, Jiangyu Li, Shaun Roux, Qian Li, Dongmei Zou, Kai Ma* and Xiaofeng Bao*


DOI: 10.2174/1567205018666211022091110




The Janus-like Association between Proton Pump Inhibitors and Dementia

, 2021; 18(6): 453 - 469

Anna Papazoglou, Muhammad I. Arshaad, Christina Henseler, Johanna Daubner, Karl Broich, Britta Haenisch and Marco Weiergräber*


DOI: 10.2174/1567205018666210929144740




Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk

, 2021; 18(5): 443 - 451

P.D. Fransquet, P. Lacaze, R. Saffery, R.C. Shah, R. Vryer, A. Murray, R.L. Woods and J. Ryan*


DOI: 10.2174/1567205018666210823100721



High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice

, 2021; 18(4): 310 - 325

Xiaokang Gong, Zheng Liang, Wei Liu, Yang Zhao, Youhua Yang, Mengjuan Wu, Jinting Shang, Yifan Xiao, Yong Mei, Qiqi Su, Binlian Sun, Jian Bao* and Xiji Shu*


DOI: 10.2174/1567205018666210628100812



Open Access Articles

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD

, 2021; 18(9): 711 - 720

Annie G. Bryant, Mary K. Manhard, David H. Salat, Bruce R. Rosen, Bradley T. Hyman, Keith A. Johnson, Susie Huang, Rachel E. Bennett and Yi-Fen Yen*




Microglia and its Genetics in Alzheimer's Disease

, 2021; 18(9): 676 - 688

Xinyan Liang , Haijian Wu, Mark Colt , Xinying Guo, Brock Pluimer , Jianxiong Zeng, Shupeng Dong and Zhen Zhao*






The Janus-like Association between Proton Pump Inhibitors and Dementia

, 2021; 18(6): 453 - 469

Anna Papazoglou, Muhammad I. Arshaad, Christina Henseler, Johanna Daubner, Karl Broich, Britta Haenisch and Marco Weiergräber*





Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice

, 2021; 18(4): 283 - 297

Katherine R. Sadleir*, Jelena Popovoic, Wei Zhu, Cory T. Reidel, Ha Do, Richard B. Silverman and Robert Vassar




Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia

, 2021; 18(4): 273 - 282

Fritjof Reinhardt, Nikolaos Scarmeas, Rajesh Karan, Uday K. Veldandi, Sunil Modali*, Krishna Duvvuri and Rashid K. Pathan




Clinical Phenotype and Mutation Spectrum of Alzheimer’s Disease with Causative Genetic Mutation in a Chinese Cohort

, 2021; 18(3): 265 - 272

Chenhui Mao, Jie Li, Liling Dong, Xinying Huang, Dan Lei, Jie Wang, Shanshan Chu, Caiyan Liu, Bin Peng, Gustavo C. Román, Liying Cui and Jing Gao*





Cerebrospinal Fluid Inflammatory Markers in Alzheimer’s Disease: Influence of Comorbidities

, 2021; 18(2): 157 - 170

Ying Wang, Ceren Emre, Helena Gyllenhammar-Schill, Karin Fjellman, Helga Eyjolfsdottir, Maria Eriksdotter, Marianne Schultzberg and Erik Hjorth*





Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study

, 2020; 17(10): 881 - 892

Bojana Petek*, Hong Xu, Marta Villa-Lopez, Bengt Winblad, Milica G. Kramberger, Maria Eriksdotter and Sara Garcia-Ptacek*




Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia

, 2020; 17(8): 709 - 721

Agnieszka Kulczyńska-Przybik*, Agnieszka Słowik, Piotr Mroczko, Bartłomiej Borawski, Magdalena Groblewska, Renata Borawska and Barbara Mroczko




The Parietal Atrophy Score on Brain Magnetic Resonance Imaging is a Reliable Visual Scale

, 2020; 17(6): 534 - 539

David Silhan, Ales Bartos*, Jana Mrzilkova, Olga Pashkovska, Ibrahim Ibrahim and Jaroslav Tintera





Most Cited Articles






Review Article

Mitigating Alzheimer’s disease with natural polyphenols: A review

, 2019; 16(6): 529-543.

Roger Gaudreault* and Normand Mousseau*


DOI: 10.2174/1567205016666190315093520


Review Article

Learning from the past: A review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer’s disease

, 2020; 17(2): 112-125.

Kelly Ceyzériat, Thomas Zilli, Philippe Millet, Giovanni B. Frisoni, Valentina Garibotto and Benjamin B. Tournier*


DOI: 10.2174/1567205017666200304085513


Research Article

Resveratrol rescues tau-induced cognitive deficits and neuropathology in a mouse model of tauopathy

, 2019; 16(8): 710-722.

Xiao-Ying Sun, Quan-Xiu Dong, Jie Zhu, Xun Sun, Li-Fan Zhang, Mandy Qiu, Xiao-Lin Yu* and Rui-Tian Liu*


DOI: 10.2174/1567205016666190801153751


Review Article

Neuroinflammation in alzheimer’s disease: Microglia, molecular participants and therapeutic choices

, 2019; 16(7): 659-674.

Haijun Wang, Yin Shen, Haoyu Chuang, Chengdi Chiu, Youfan Ye and Lei Zhao*


DOI: 10.2174/1567205016666190503151648



Systemic Review Article

Midlife modifiable risk factors for dementia: A systematic review and meta-analysis of 34 prospective cohort studies

, 2019; 16(14): 1254-1268.

Xiao-Ying Li , Min Zhang*, Wei Xu, Jie-Qiong Li, Xi-Peng Cao , Jin-Tai Yu * and Lan Tan*


DOI: 10.2174/1567205017666200103111253


Research Article

The temporal relationship between pain intensity and pain interference and incident dementia

, 2019; 16(2): 109-115.

Ali Ezzati*, Cuiling Wang, Mindy J. Katz, Carol A. Derby, Andrea R. Zammit, Molly E. Zimmerman, Jelena M. Pavlovic, Martin J. Sliwinski and Richard B. Lipton


DOI: 10.2174/1567205016666181212162424


Systematic Review Article

Physical activity as a moderator of alzheimer pathology: A systematic review of observational studies

, 2019; 16(4): 362-378.

Kristian Steen Frederiksen*, Le Gjerum, Gunhild Waldemar and Steen Gregers Hasselbalch


DOI: 10.2174/1567205016666190315095151


Research Article

A pilot study of exenatide actions in alzheimer’s disease

, 2019; 16(8): 741-752.

Roger J. Mullins, Maja Mustapic, Chee W. Chia, Olga Carlson, Seema Gulyani, Joyce Tran, Yazhou Li, Mark P. Mattson, Susan Resnick, Josephine M. Egan, Nigel H. Greig and Dimitrios Kapogiannis*


DOI: 10.2174/1567205016666190913155950


Review Article

Pharmacological interventions to attenuate Alzheimer’s disease progression: The story so far

, 2019; 16(3): 261-277.

Firas H. Bazzari*, Dalaal M. Abdallah and Hanan S. El-Abhar


DOI: 10.2174/1567205016666190301111120



Most Accessed Articles

Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk

, 2021; 18(5): 443-451.

P.D. Fransquet, P. Lacaze, R. Saffery, R.C. Shah, R. Vryer, A. Murray, R.L. Woods and J. Ryan*


DOI: 10.2174/1567205018666210823100721



Risk Factors for Alzheimer’s Disease: An Epidemiological Study

, 2021; 18(5): 372-379.

Jana Janoutová*, Martina Kovalová, Ondřej Machaczka, Petr Ambroz, Anna Zatloukalová, Kateřina Němček and Vladimír Janout


DOI: 10.2174/1567205018666210820124135



Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study

, 2021; 18(5): 399-413.

Bibek Gyanwali, Benedict Lui, Chuen S. Tan, Eddie J.Y. Chong, Henri Vrooman, Christopher Chen and Saima Hilal*


DOI: 10.2174/1567205018666210820125543


Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity

, 2021; 18(5): 414-427.

Anne Kasus-Jacobi*, Jennifer L. Washburn, Craig A. Land and Heloise Anne Pereira


DOI: 10.2174/1567205018666210823095044


Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer’s Disease

, 2021; 18(5): 428-442.

Rui Zhou, Li-li Chen, Hai Yang, Ling Li, Juan Liu, Le Chen, Wen-Juan Hong, Cong-guo Wang, Jing-Jing Ma, Jie Huang, Xin-Fu Zhou, Dong Liu and Hua-Dong Zhou*


DOI: 10.2174/1567205018666210906092940


Robust Discovery of Mild Cognitive Impairment Subtypes and Their Risk of Alzheimer's Disease Conversion Using Unsupervised Machine Learning and Gaussian Mixture Modeling

, 2021; 18(7): 595-606.

Fahimeh Nezhadmoghadam*, Antonio Martinez-Torteya, Victor Treviño, Emmanuel Martínez, Alejandro Santos, Jose Tamez-Peña and Alzheimer’s Disease Neuroimaging Initiative


DOI: 10.2174/1567205018666210831145825


Microglia and its Genetics in Alzheimer's Disease

, 2021; 18(9): 676-688.

Xinyan Liang , Haijian Wu, Mark Colt , Xinying Guo, Brock Pluimer , Jianxiong Zeng, Shupeng Dong and Zhen Zhao*


DOI: 10.2174/1567205018666211105140732


Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study

, 2021; 18(8): 607-622.

Anna Mengr, Lucie Hrubá, Aneta Exnerová, Martina Holubová, Andrea Popelová, Blanka Železná, Jaroslav Kuneš and Lenka Maletínská*


DOI: 10.2174/1567205018666210922110652


Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ε4 Allele in Alzheimer’s Disease

, 2021; 18(7): 585-594.

Mirjana B. Leko, Matea N. Perković, Gordana N. Erjavec, Nataša Klepac, Dubravka Š. Štrac, Fran Borovečki, Nela Pivac, Patrick R. Hof and Goran Šimić*


DOI: 10.2174/1567205018666210917162843


A Novel Probiotic Formula, BIOCG, Protects Against Alzheimer’s-Related Cognitive Deficits via Regulation of Dendritic Spine Dynamics

, 2021; 18(7): 558-572.

Miao Sun*, Wenchenyang Bao, Chengyu Huang, Ziyue Xia, Changliang Zhang, Guangxian Wang, Runxin Wang, Jiangyu Li, Shaun Roux, Qian Li, Dongmei Zou, Kai Ma* and Xiaofeng Bao*


DOI: 10.2174/1567205018666211022091110


Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer’s Disease Patients: How to Measure and Use It

, 2021; 18(7): 533-545.

Rosanna Squitti*, Mariacarla Ventriglia, Alberto Granzotto, Stefano L. Sensi and Mauro Ciro A. Rongioletti


DOI: 10.2174/1567205018666211022085755






Editor-in-Chief

graphic
Debomoy K. Lahiri
(16607 citations)
Department of Psychiatry
Indiana University School of Medicine
Indianapolis, IN
(United States)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Alzheimer Research was introduced in 2004 with the assistance of Dr. Debomoy K. Lahiri, who is the current Editor-in-Chief serving since 2004.
New eBook

ebook-cover

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog